Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.38
Delayed Data
As of Mar 02
 -0.02 / -0.83%
Today’s Change
2.18
Today|||52-Week Range
6.60
-10.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
AssetsCash31.3M30.1M81.5M48.5M
 
 
 
 
 
Short Term Investment Cash-12.8M-1.2M51.4M-33.0M
 
 
 
 
 
Cash & Short Term Investments51.0M39.7M100.6M91.5M
 
 
 
 
 
 
ReceivablesReceivables116.0K0.000.000.00
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets431.0K561.0K786.0K765.0K
 
 
 
 
 
Current Assets51.5M40.3M101.4M92.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross20.1M20.7M21.3M22.0M
 
 
 
 
 
Depreciation-18.0M-19.3M-20.1M-20.5M
 
 
 
 
 
Other Assets366.0K631.0K458.0K1.4M
 
 
 
 
 
Total Assets54.1M42.3M103.0M95.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.9M3.5M5.7M6.6M
 
 
 
 
 
Short Term Debt3.5M4.2M7.9M9.5M
 
 
 
 
 
Accrued Expenses3.8M4.5M6.6M13.0M
 
 
 
 
 
Other Current Liabilities8.4M4.5M6.6M13.0M
 
 
 
 
 
Other Liabilities16.7M15.1M23.5M32.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt11.7M12.4M4.5M13.9M
 
 
 
 
 
Total Liabilities30.6M27.6M28.0M46.1M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity23.5M14.8M75.1M49.1M
 
 
 
 
 
Total Shareholder Equity23.5M14.8M75.1M49.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding42.1M49.5M68.9M85.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account